Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
1521.HK Stock Summary
Top 10 Correlated ETFs
1521.HK
In the News
1521.HK Financial details
Company Rating
Buy
Market Cap
3.17B
Income
39.92M
Revenue
478.03M
Book val./share
0.16
Cash/share
0.04
Dividend
-
Dividend %
-
Employees
1.61K
Optionable
No
Shortable
Yes
Earnings
28 Mar 2024
P/E
22.7
Forward P/E
-
PEG
2
P/S
2.35
P/B
1.75
P/C
36
P/FCF
40.87
Quick Ratio
0.93
Current Ratio
1.76
Debt / Equity
0.18
LT Debt / Equity
0.12
-
-
EPS (TTM)
0.02
EPS next Y
0
EPS next Q
-
EPS this Y
40%
EPS next Y
-88.47%
EPS next 5Y
-89.59%
EPS last 5Y
17.61%
Revenue last 5Y
24.67%
Revenue Q/Q
-2.34%
EPS Q/Q
-64.52%
-
-
-
-
SMA20
-50%
SMA50
-50%
SMA100
-50%
Inst Own
-
Inst Trans
-
ROA
5%
ROE
8%
ROC
0.09%
Gross Margin
36%
Oper. Margin
16%
Profit Margin
10%
Payout
-
Shs Outstand
2.1B
Shs Float
672.75M
-
-
-
-
Target Price
-
52W Range
1.49-2.68
52W High
-28%
52W Low
+44%
RSI
37
Rel Volume
0.09
Avg Volume
5.91M
Volume
534K
Perf Week
-7.1%
Perf Month
-19.55%
Perf Quarter
-22.58%
Perf Half Y
-26.15%
-
-
-
-
Beta
0.829
-
-
Volatility
0.03%, 0.12%
Prev Close
0%
Price
1.44
Change
0.7%
1521.HK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.04 | 0.06 | 0.06 | 0.09 | 0.12 | |
Net income per share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Operating cash flow per share | 0.01 | 0.01 | 0.02 | 0.02 | 0.03 | |
Free cash flow per share | 0.01 | 0 | 0.01 | 0 | 0.01 | |
Cash per share | 0.01 | 0.12 | 0.11 | 0.07 | 0.04 | |
Book value per share | 0.02 | 0.15 | 0.14 | 0.16 | 0.16 | |
Tangible book value per share | 0.02 | 0.14 | 0.12 | 0.11 | 0.07 | |
Share holders equity per share | 0.02 | 0.15 | 0.14 | 0.16 | 0.16 | |
Interest debt per share | 0 | 0.01 | 0.02 | 0.03 | 0.03 | |
Market cap | 858.52M | 1.02B | 1.11B | 1.04B | 760.92M | |
Enterprise value | 851.06M | 835.47M | 941.68M | 951.37M | 791.67M | |
P/E ratio | 76.37 | 55.49 | 64.91 | 56.34 | 29.57 | |
Price to sales ratio | 10.33 | 10.18 | 8.85 | 5.63 | 3.04 | |
POCF ratio | 37.89 | 54.59 | 35.17 | 23.3 | 12.19 | |
PFCF ratio | 49.23 | 175.26 | 65.18 | -178.04 | 51.49 | |
P/B Ratio | 19.68 | 3.86 | 3.87 | 3.25 | 2.28 | |
PTB ratio | 19.68 | 3.86 | 3.87 | 3.25 | 2.28 | |
EV to sales | 10.24 | 8.32 | 7.48 | 5.16 | 3.16 | |
Enterprise value over EBITDA | 45.1 | 44.49 | 40.59 | 22.35 | 14.63 | |
EV to operating cash flow | 37.56 | 44.61 | 29.75 | 21.36 | 12.68 | |
EV to free cash flow | 48.8 | 143.23 | 55.14 | -163.16 | 53.57 | |
Earnings yield | 0.01 | 0.02 | 0.02 | 0.02 | 0.03 | |
Free cash flow yield | 0.02 | 0.01 | 0.02 | -0.01 | 0.02 | |
Debt to equity | 0.2 | 0.08 | 0.14 | 0.18 | 0.18 | |
Debt to assets | 0.11 | 0.07 | 0.11 | 0.12 | 0.11 | |
Net debt to EBITDA | -0.4 | -9.95 | -7.39 | -2.04 | 0.57 | |
Current ratio | 1.49 | 8.34 | 5.59 | 2.89 | 1.76 | |
Interest coverage | 38.53 | 11.8 | 7.14 | 9.81 | 8.5 | |
Income quality | 1.61 | 1.02 | 1.85 | 2.42 | 2.43 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0.03 | |
Payout ratio | 0 | 0 | 0 | 0 | 0.98 | |
Sales general and administrative to revenue | 0.2 | 0.16 | 0.15 | 0.18 | 0.18 | |
Research and developement to revenue | 0.02 | 0.02 | 0.01 | 0.01 | 0.02 | |
Intangibles to total assets | 0 | 0.04 | 0.1 | 0.22 | 0.33 | |
Capex to operating cash flow | -0.23 | -0.69 | -0.46 | -1.13 | -0.76 | |
Capex to revenue | -0.06 | -0.13 | -0.12 | -0.27 | -0.19 | |
Capex to depreciation | -1.21 | -1.73 | -1.23 | -2.14 | -1.62 | |
Stock based compensation to revenue | 0 | 0.03 | 0.01 | 0.04 | 0.02 | |
Graham number | 0.05 | 0.18 | 0.17 | 0.18 | 0.21 | |
ROIC | 0.21 | 0.04 | 0.04 | 0.04 | 0.05 | |
Return on tangible assets | 0.15 | 0.06 | 0.05 | 0.05 | 0.07 | |
Graham Net | 0 | 0.1 | 0.07 | 0.02 | -0.04 | |
Working capital | 14.45M | 213.33M | 208.86M | 138.08M | 74.37M | |
Tangible asset value | 43.61M | 251.45M | 249.17M | 219.94M | 153.18M | |
Net current asset value | 10.36M | 192.42M | 160.55M | 58.31M | -42.91M | |
Invested capital | 0.2 | 0.08 | 0.14 | 0.18 | 0.18 | |
Average receivables | 22.58M | 23.05M | 27.47M | 38.44M | 55.18M | |
Average payables | 3.39M | 4.13M | 6.05M | 9.44M | 11.23M | |
Average inventory | 36.5K | 123K | 448.5K | 835K | 2.07M | |
Days sales outstanding | 95.44 | 88.6 | 88.67 | 91.67 | 93.35 | |
Days payables outstanding | 26.5 | 27.1 | 32.07 | 35.54 | 24.91 | |
Days of inventory on hand | 0.54 | 1 | 3.13 | 2.93 | 7.21 | |
Receivables turnover | 3.82 | 4.12 | 4.12 | 3.98 | 3.91 | |
Payables turnover | 13.77 | 13.47 | 11.38 | 10.27 | 14.65 | |
Inventory turnover | 674.19 | 364.88 | 116.47 | 124.46 | 50.6 | |
ROE | 0.26 | 0.07 | 0.06 | 0.06 | 0.08 | |
Capex per share | 0 | -0.01 | -0.01 | -0.02 | -0.02 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
Metric | History | 2021-06-30 | 2021-12-31 | 2022-06-30 | 2022-12-31 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.04 | 0.05 | 0.06 | 0.06 | 0.06 | |
Net income per share | 0 | 0 | 0.01 | 0.01 | 0 | |
Operating cash flow per share | 0.01 | 0.02 | 0.01 | 0.02 | 0.01 | |
Free cash flow per share | -0.01 | 0 | 0 | 0.01 | 0 | |
Cash per share | 0.09 | 0.07 | 0.04 | 0.04 | 0.04 | |
Book value per share | 0.15 | 0.16 | 0.16 | 0.16 | 0.16 | |
Tangible book value per share | 0.13 | 0.11 | 0.08 | 0.07 | 0.08 | |
Share holders equity per share | 0.15 | 0.16 | 0.16 | 0.16 | 0.16 | |
Interest debt per share | 0.02 | 0.03 | 0.01 | 0.03 | 0.03 | |
Market cap | 2.17B | 1.04B | 819.63M | 766.22M | 532.79M | |
Enterprise value | 2.04B | 952.46M | 819.15M | 796.98M | 570.59M | |
P/E ratio | 61.52 | 27.09 | 15.83 | 14.98 | 29.01 | |
Price to sales ratio | 25.54 | 10.46 | 6.89 | 5.83 | 4.15 | |
POCF ratio | 175 | 32.35 | 33.44 | 20.2 | 46.79 | |
PFCF ratio | -135.27 | 101.47 | 218.92 | 68.86 | -6.34K | |
P/B Ratio | 7.02 | 3.25 | 2.52 | 2.3 | 1.58 | |
PTB ratio | 7.02 | 3.25 | 2.52 | 2.3 | 1.58 | |
EV to sales | 23.93 | 9.59 | 6.89 | 6.06 | 4.45 | |
Enterprise value over EBITDA | 115.37 | 38.24 | 30.66 | 29.6 | 28.05 | |
EV to operating cash flow | 163.94 | 29.65 | 33.42 | 21.01 | 50.11 | |
EV to free cash flow | -126.72 | 93 | 218.79 | 71.63 | -6.79K | |
Earnings yield | 0 | 0.01 | 0.02 | 0.02 | 0.01 | |
Free cash flow yield | -0.01 | 0.01 | 0 | 0.01 | 0 | |
Debt to equity | 0.15 | 0.18 | 0.06 | 0.18 | 0.18 | |
Debt to assets | 0.11 | 0.12 | 0.04 | 0.11 | 0.12 | |
Net debt to EBITDA | -7.78 | -3.48 | -0.02 | 1.14 | 1.86 | |
Current ratio | 5 | 2.89 | 1.81 | 1.76 | 2.08 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 1.41 | 3.35 | 1.89 | 2.97 | 2.48 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.16 | 0.19 | 0.18 | 0.17 | 0.18 | |
Research and developement to revenue | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | |
Intangibles to total assets | 0.1 | 0.22 | 0.35 | 0.33 | 0.33 | |
Capex to operating cash flow | -2.29 | -0.68 | -0.85 | -0.71 | -1.01 | |
Capex to revenue | -0.33 | -0.22 | -0.17 | -0.2 | -0.09 | |
Capex to depreciation | -3.22 | -1.49 | -1.58 | -1.65 | -0.68 | |
Stock based compensation to revenue | 0.04 | 0.04 | 0.02 | 0.02 | 0.02 | |
Graham number | 0.12 | 0.13 | 0.15 | 0.15 | 0.09 | |
ROIC | 0.02 | 0.02 | 0.03 | 0.02 | 0.01 | |
Return on tangible assets | 0.02 | 0.03 | 0.04 | 0.03 | 0.01 | |
Graham Net | 0.06 | 0.02 | -0.02 | -0.04 | -0.03 | |
Working capital | 194.73M | 138.08M | 67.05M | 74.37M | 86.32M | |
Tangible asset value | 271.81M | 219.94M | 157.12M | 153.18M | 159.99M | |
Net current asset value | 145.97M | 58.31M | -14.95M | -42.91M | -31.52M | |
Invested capital | 0.15 | 0.18 | 0.06 | 0.18 | 0.18 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 43.19 | 41.98 | 40.54 | 43.85 | 47.62 | |
Days payables outstanding | 13.28 | 16.57 | 13.27 | 11.45 | 11.43 | |
Days of inventory on hand | 1.39 | 1.37 | 3.03 | 3.32 | 3.54 | |
Receivables turnover | 2.08 | 2.14 | 2.22 | 2.05 | 1.89 | |
Payables turnover | 6.78 | 5.43 | 6.78 | 7.86 | 7.87 | |
Inventory turnover | 64.87 | 65.83 | 29.69 | 27.14 | 25.4 | |
ROE | 0.03 | 0.03 | 0.04 | 0.04 | 0.01 | |
Capex per share | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
1521.HK Frequently Asked Questions
What is Frontage Holdings Corporation stock symbol ?
Frontage Holdings Corporation is a HK stock , located in Exton of Pa and trading under the symbol 1521.HK
What is Frontage Holdings Corporation stock quote today ?
Frontage Holdings Corporation stock price is $1.44 today.
Is Frontage Holdings Corporation stock public?
Yes, Frontage Holdings Corporation is a publicly traded company.